Archive

A new method for sampling African swine fever virus genome and its inactivation in environmental samples 🇬🇧

The VACDIVA Project, which will last the following four years, aims to develop an effective vaccine against African Swine Fever (ASF). The vaccine would solve the current problem in Europe...

10 noviembre, 2021

VACDIVA: 1st International Workshop for the Pig Industry

The VACDIVA Project, which will last the following four years, aims to develop an effective vaccine against African Swine Fever (ASF). The vaccine would solve the current problem in Europe...

13 septiembre, 2021

African swine fever vaccine: Turning a dream into reality 🇬🇧

The VACDIVA Project, which will last the following four years, aims to develop an effective vaccine against African Swine Fever (ASF). The vaccine would solve the current problem in Europe...

02 julio, 2021

The Role of Interleukine-10 and Interferon-γ as Potential Markers of the Evolution of African Swine Fever Virus Infection in Wild Boar 🇬🇧

The VACDIVA Project, which will last the following four years, aims to develop an effective vaccine against African Swine Fever (ASF). The vaccine would solve the current problem in Europe...

16 junio, 2021

Combined Short and Long-Read Sequencing Reveals a Complex Transcriptomic Architecture of African Swine Fever Virus 🇬🇧

The VACDIVA Project, which will last the following four years, aims to develop an effective vaccine against African Swine Fever (ASF). The vaccine would solve the current problem in Europe...

06 mayo, 2021

A Simple Method for Sample Preparation to Facilitate Efficient Whole-Genome Sequencing of African Swine Fever Virus 🇬🇧

The VACDIVA Project, which will last the following four years, aims to develop an effective vaccine against African Swine Fever (ASF). The vaccine would solve the current problem in Europe...

06 mayo, 2021

High Doses of Inactivated African Swine Fever Virus Are Safe, but Do Not Confer Protection against a Virulent Challenge 🇬🇧

The VACDIVA Project, which will last the following four years, aims to develop an effective vaccine against African Swine Fever (ASF). The vaccine would solve the current problem in Europe...

21 abril, 2021

Working together as the answer to eradicate ASFv

The VACDIVA Project, which will last the following four years, aims to develop an effective vaccine against African Swine Fever (ASF). The vaccine would solve the current problem in Europe...

22 marzo, 2021

Identification of potential inhibitors of protein-protein interaction useful to fight against Ebola and other highly pathogenic viruses 🇬🇧

The VACDIVA Project, which will last the following four years, aims to develop an effective vaccine against African Swine Fever (ASF). The vaccine would solve the current problem in Europe...

03 marzo, 2021

African Swine Fever Virus Ubiquitin-Conjugating Enzyme Interacts With Host Translation Machinery to Regulate the Host Protein Synthesis 🇬🇧

The VACDIVA Project, which will last the following four years, aims to develop an effective vaccine against African Swine Fever (ASF). The vaccine would solve the current problem in Europe...

03 marzo, 2021